Molecular Features Underlying Discordance Between Clinical and Genomic Risk Stratification in Localized Prostate Cancer in Over 280, 000 Patients
Year: 2026
Type: article
Study design: Observational Study
Source: Clinical Cancer Research
Authors: Michael J. Zelefsky, Hyunnam Ryu, Xin Zhao, Qi Joslove. Xu, Mohammed Alshalalfa, Yang Liu, Marla Johnson, Elai Davicioni, James A. Proudfoot, Tyler M. Seibert, Sarah Howlett, Gerhardt Attard, Melvin L.K. Chua, Edward M. Schaeffer, Adam B. Weiner, Matthew R. Cooperberg, Ashley E. Ross, Krishnan R. Patel, Phuoc Tran, Himanshu Nagar, Michael Leapman, David Wise, Daniel E. Spratt, Angela Y. Jia
Institutions: NYU Langone Health, Veracyte (United States), University of California San Diego, University College London, National Cancer Centre Singapore, Northwestern University, Cedars-Sinai Medical Center, University of California, San Francisco, Northwestern Medicine, The University of Texas MD Anderson Cancer Center, University of Maryland, College Park, Memorial Sloan Kettering Cancer Center, Yale University, University Hospitals Cleveland Medical Center, University Hospitals of Cleveland
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7235183373
